PET-CT Cancer Screening in Korea: What It Detects and What It Costs
PET-CT is the most powerful cancer screening tool available in routine clinical practice. It can detect tumors as small as 7-8mm, sometimes smaller, across the entire body in a single scan. In the United States, a PET-CT costs $3,000-$6,000 and is almost never covered by insurance for screening purposes (only for diagnosed cancer staging). In Korea, the same scan costs $800-$1,500 and is included in premium health checkup packages at major hospitals.
This cost and accessibility gap is one of the primary reasons American and European patients fly to Korea for thorough health screenings. A PET-CT scan that your US doctor might only order after a cancer diagnosis, by which time you’re in treatment mode rather than prevention mode, is available in Korea as a preventive screening tool for anyone who wants it.
This guide covers the science behind PET-CT, what it can and cannot detect, who should consider it, the real costs at Korean hospitals, and what you need to know about false positives and radiation exposure.
What Is a PET-CT Scan?
PET-CT combines two imaging technologies into a single scan:
PET (Positron Emission Tomography)
PET scanning detects metabolic activity. Before the scan, you’re injected with a small amount of FDG (fluorodeoxyglucose), a radioactive glucose tracer. FDG behaves like regular glucose in your body: it goes wherever glucose goes. Cancer cells consume glucose at 3-8x the rate of normal cells (a phenomenon called the Warburg effect, discovered in the 1920s). The PET scanner detects the concentrated FDG signal in areas of abnormally high metabolic activity.
In simple terms: cancer cells are hungry. They eat more sugar than normal cells. PET finds the cells that are eating too much.
CT (Computed Tomography)
CT provides detailed anatomical images, the structural map of your body. It uses X-rays taken from multiple angles to create cross-sectional images of your organs, bones, and tissues.
Why Combining Them Matters
PET alone tells you “something metabolically active is here” but doesn’t show precise anatomy. CT alone shows anatomy but can’t distinguish a benign lump from an active tumor. Together, PET-CT provides both: “there’s abnormal metabolic activity, and it’s located in this specific spot in this specific organ.”
The fused PET-CT image is the most informative single imaging study available for cancer detection and staging.
What Cancers Can PET-CT Detect?
PET-CT is effective for detecting most solid tumors. Its sensitivity varies by cancer type:
High Detection Sensitivity (>85% sensitivity)
| Cancer Type | PET-CT Sensitivity | Notes |
|---|---|---|
| Lung cancer | 90-95% | Excellent for nodules >8mm; limited for ground-glass opacities |
| Lymphoma (Hodgkin’s and NHL) | 90-100% | Gold standard for lymphoma staging |
| Melanoma (metastatic) | 85-95% | Detects distant metastases effectively |
| Head and neck cancers | 85-95% | Identifies primary tumors and lymph node involvement |
| Esophageal cancer | 85-90% | |
| Colorectal cancer | 85-95% | Better for metastases than primary detection |
| Cervical cancer | 85-90% | Excellent for lymph node staging |
Moderate Detection Sensitivity (65-85%)
| Cancer Type | PET-CT Sensitivity | Notes |
|---|---|---|
| Breast cancer | 70-85% | Better for inflammatory and locally advanced; limited for small primary tumors |
| Thyroid cancer | 70-80% | Variable; depends on histological subtype |
| Stomach cancer | 65-85% | Limited for early-stage mucosal disease |
| Pancreatic cancer | 70-85% | Can miss small tumors; pancreatitis causes false positives |
| Ovarian cancer | 70-85% | Better for recurrence detection than primary screening |
Limited Detection Sensitivity (<65%)
| Cancer Type | PET-CT Sensitivity | Notes |
|---|---|---|
| Prostate cancer | 40-60% | Low FDG avidity; PSMA PET is now preferred |
| Kidney cancer (renal cell) | 50-65% | FDG is excreted by kidneys, limiting detection |
| Bladder cancer | 40-55% | Same urinary excretion issue |
| Hepatocellular carcinoma (liver) | 50-65% | Well-differentiated HCC has low FDG uptake |
| Brain tumors (primary) | Variable | Normal brain has high glucose metabolism, reducing contrast |
| Mucinous cancers | 50-70% | Low metabolic activity in mucinous tumors |
What PET-CT Cannot Reliably Detect
- Very small tumors (<7mm): below the scanner’s spatial resolution
- Slow-growing, well-differentiated tumors: these may not consume enough glucose to create a detectable signal
- Cancers in organs that naturally concentrate FDG: brain (high baseline glucose metabolism) and urinary tract (FDG is excreted in urine)
- Carcinoma in situ (pre-cancerous changes): too small and not metabolically distinct enough
This is why PET-CT should always be part of a full screening, not the only screening. Korean hospital checkup packages pair PET-CT with endoscopy (for stomach/colon cancer), ultrasound (for liver/thyroid/breast), and blood tumor markers to cover the gaps.
PET-CT Costs: Korea vs. US
| Item | Korea | United States |
|---|---|---|
| PET-CT whole body (standalone) | $800-$1,500 | $3,000-$6,000 |
| PET-CT as part of VIP checkup package | Included in $4,000-$6,500 package | Not available as screening |
| PET-CT as part of premium checkup | Add-on: $800-$1,200 to package price | Not available as screening |
| PSMA PET-CT (prostate-specific) | $1,200-$2,000 | $3,500-$7,000 |
| Insurance coverage (US) | N/A | Covered only for diagnosed cancer staging, not screening |
The Insurance Problem in the US
In the United States, PET-CT for cancer screening (in patients without a cancer diagnosis) is considered “not medically necessary” by virtually all insurance carriers, including Medicare. You can get a PET-CT scan ordered by your doctor for staging a known cancer, but not for detecting an unknown cancer.
The logic is circular: you need a diagnosis to get the test that could provide the diagnosis.
In Korea, PET-CT is available to anyone as an elective screening tool. No referral required. No pre-authorization. No insurance argument. Walk into a hospital health checkup center, add PET-CT to your package, and get scanned the same morning.
Which Korean Hospital Checkup Packages Include PET-CT?
At our partner hospitals, PET-CT is included in the following packages:
Korea University Anam Hospital
- VIP Comprehensive Checkup ($4,500-$6,000): Includes whole-body PET-CT, brain MRI/MRA, cardiac CT, full endoscopy, 70+ blood markers, and 1:1 dedicated coordinator
- Cancer-Focused Screening ($3,000-$4,500): PET-CT + tumor markers + organ-specific imaging based on risk factors
- Add-on to any package: PET-CT can be added to basic or premium checkups for $800-$1,200
Severance Hospital
- Yonsei Executive Health ($5,000-$6,500): Full PET-CT included alongside brain MRI, cardiac workup, and comprehensive screening
- Cancer Risk Assessment ($3,500-$5,000): PET-CT + genetic cancer risk panels + full endoscopy
- Standalone PET-CT: Available by appointment for $1,000-$1,500
Seoul St. Mary’s Hospital
- Premium Health Screening ($4,000-$5,500): PET-CT + comprehensive panels
- Oncology-Focused Package: Designed for patients with family cancer history; PET-CT + colonoscopy + gastroscopy + breast/thyroid ultrasound + tumor markers
Bucheon St. Mary’s Hospital
- Comprehensive Cancer Screening ($3,500-$5,000): PET-CT included
- Cost advantage: Bucheon St. Mary’s often offers slightly lower pricing than Seoul hospitals for equivalent packages, with the added convenience of proximity to Incheon International Airport
Who Should Consider PET-CT Screening?
PET-CT involves radiation exposure and cost. It’s not appropriate for every patient. Based on Korean hospital screening guidelines and international oncology practice, PET-CT screening is most valuable for:
High-Value Candidates
- Age 50+ with no recent comprehensive cancer screening
- Strong family history of cancer (first-degree relative with cancer before age 50, or multiple family members with cancer)
- Personal history of cancer in remission. PET-CT is the standard for recurrence monitoring
- Chronic smokers (current or former, 20+ pack-years). Extremely high lung cancer risk
- Occupational exposure to known carcinogens (asbestos, benzene, radiation, certain chemicals)
- Chronic hepatitis B or C carriers, with elevated liver cancer risk
- Obesity (BMI 30+), associated with increased risk of multiple cancer types
Moderate-Value Candidates
- Age 40-50 with some risk factors
- Health-conscious individuals who want maximum screening as part of a comprehensive checkup
- Patients with unexplained symptoms (persistent weight loss, unexplained pain, chronic fatigue) that haven’t been diagnosed by standard testing
Low-Value Candidates (Consider Whether Needed)
- Under 40 with no risk factors. Cancer prevalence is low in this group, and the risk of false positives (leading to unnecessary follow-up procedures and anxiety) may outweigh the screening benefit
- Patients who had a thorough screening including PET-CT within the last 2 years. Repeat screening at shorter intervals has diminishing returns
Your decision should be informed by your personal risk profile, family history, age, and overall health goals. Korean hospital screening coordinators, and InKoreaNow, can help you determine whether PET-CT is appropriate for your situation.
The PET-CT Procedure: What to Expect
Preparation (Starting the Night Before)
- Fasting: No food for 6+ hours before the scan. Water is allowed. This ensures your blood glucose is low, which improves FDG uptake in abnormal cells.
- No strenuous exercise for 24 hours before the scan. Exercise increases muscle glucose uptake, which can interfere with interpretation.
- Diabetic patients: Special preparation is required. Blood glucose must be below 200 mg/dL for accurate results. Your doctor will advise on insulin/medication timing.
- Inform staff about any medications you’re taking, recent surgeries, active infections, or inflammatory conditions.
The Day of the Scan
Step 1: Check-in and blood glucose test (15 minutes)
A nurse checks your blood glucose level. If it’s above 200 mg/dL, the scan may be rescheduled.
Step 2: FDG injection (5 minutes)
A small IV line is placed, and the FDG tracer is injected. The amount of radioactivity is small, roughly equivalent to the radiation from a conventional CT scan. You’ll feel nothing from the injection itself.
Step 3: Uptake period (45-60 minutes)
This is the waiting period while FDG distributes throughout your body. You’ll rest in a quiet, dimly lit room. Stay calm and still. Physical activity, talking, and even chewing gum can increase muscle uptake and create artifacts. Some hospitals provide a reclining chair; others have private resting rooms.
Step 4: The scan (20-30 minutes)
You lie on a table that passes slowly through a large, donut-shaped scanner. It’s not as enclosed as an MRI, and most patients do not experience claustrophobia. You need to stay still. The technologist communicates with you through an intercom.
Step 5: After the scan
You can eat and drink immediately after. The FDG will be naturally cleared from your body through urination within 6-12 hours. Drink plenty of water to help flush the tracer. The radiation exposure is minimal and poses no risk to people around you, though some hospitals recommend avoiding close contact with pregnant women and infants for a few hours.
Total time at the hospital for PET-CT: approximately 2-3 hours (including prep, uptake, and scan).
Understanding Your Results
PET-CT results are reported using the SUV (Standardized Uptake Value), a numerical measure of FDG concentration in a specific area.
- SUV 0-2.5: Generally considered normal metabolic activity
- SUV 2.5-4.0: Mildly elevated. May be inflammatory or early neoplastic; warrants monitoring or additional testing
- SUV >4.0: Concerning for malignancy. Usually requires biopsy or further investigation
Important caveats:
SUV thresholds are guidelines, not absolute rules. Some cancers have low SUV values (slow-growing tumors), and some benign conditions have high SUV values (infections, inflammation, granulomas). The radiologist interprets SUV in context: the anatomical location, the pattern of uptake, the patient’s clinical history, and correlation with other imaging and blood tests.
You should always discuss your PET-CT results with a physician, not interpret the report yourself. At our partner hospitals, results are reviewed with you by a specialist, typically the same day or the next morning.
False Positives: The Real Concern
The primary risk of PET-CT screening in healthy individuals isn’t the radiation or the cost. It’s the false positive rate.
What Causes False Positives
FDG is taken up by any metabolically active tissue, not only cancer. Common causes of false-positive PET-CT findings:
- Infection or inflammation: Active infections, recent surgery sites, inflammatory conditions (sarcoidosis, inflammatory bowel disease, arthritis)
- Brown fat activation: Cold weather or cold scan rooms can activate brown fat deposits (neck, shoulders, paravertebral), which take up FDG strongly and look abnormal
- Muscle tension: Talking, chewing, or being anxious during the uptake period can cause muscle FDG uptake
- Benign tumors/conditions: Thyroid adenomas, colon polyps, uterine fibroids
- Granulomatous diseases: Tuberculosis, fungal infections, sarcoidosis
- Post-surgical changes: Sites of recent surgery remain metabolically active for weeks to months
False Positive Rates
Published studies report false positive rates for whole-body PET-CT screening of 1.5-5% per scan in asymptomatic individuals. That means for every 100 people who get a screening PET-CT, 2-5 will have a finding that looks potentially concerning but turns out to be benign.
What Happens After a False Positive
A suspicious finding on PET-CT leads to additional testing:
- Repeat imaging (CT, MRI, or targeted ultrasound) after 3-6 months
- Biopsy of the suspicious area
- Blood tests for specific tumor markers
These follow-up procedures carry their own costs, time, anxiety, and (in the case of biopsy) small procedural risks. This is the trade-off of sensitive screening: you find more real cancers, but you also find more false alarms.
Mitigating False Positive Risk
Korean hospitals reduce false positives by:
- Correlating PET-CT with other screening results (blood markers, ultrasound, endoscopy). A finding suspicious on PET-CT but normal on all other tests is more likely benign
- Experienced radiologists at high-volume centers (like KU Anam and Severance) read thousands of PET-CTs per year, improving their ability to distinguish true positives from artifacts
- Proper patient preparation (fasting, rest, warm environment) reduces physiologic FDG uptake that causes false positives
- Immediate follow-up capability. If something suspicious is found, Korean hospitals can often perform additional testing (biopsy, focused imaging) the same day or next day, rather than weeks later
Radiation Exposure: Putting It in Perspective
PET-CT involves ionizing radiation from two sources: the FDG tracer (PET component) and the X-rays (CT component).
Typical Radiation Dose
- PET component (FDG): 5-8 mSv
- CT component (low-dose screening protocol): 5-10 mSv
- Total PET-CT: 10-18 mSv
Comparison to Other Exposures
| Exposure | Dose (mSv) |
|---|---|
| Natural background radiation (annual) | 2.4 |
| Chest X-ray | 0.02 |
| Mammogram | 0.4 |
| Abdominal CT | 8-10 |
| PET-CT | 10-18 |
| Annual dose limit for radiation workers | 50 |
| Dose linked to measurable cancer risk increase | 100+ (acute) |
Is It Safe?
A single PET-CT scan poses a very small additional cancer risk, estimated at approximately 1 in 10,000 to 1 in 1,000 over a lifetime (depending on age at exposure and specific dose). For patients over 50, this risk is negligible compared to the baseline cancer risk and the potential benefit of detecting an existing cancer early.
For younger patients (under 40), the risk-benefit calculation shifts because they have more years for radiation-induced effects to manifest. This is why PET-CT screening is generally not recommended for young, low-risk individuals.
Korean hospitals use low-dose CT protocols for screening PET-CTs, minimizing the radiation dose from the CT component while maintaining diagnostic quality for the PET overlay.
Combining PET-CT with a Full Korean Health Checkup
The most cost-effective and medically comprehensive approach is to include PET-CT as part of a full Korean health checkup. Here’s what a typical VIP screening day looks like:
Morning (7:00 AM – 12:00 PM):
1. Blood draw (fasting), 50-70+ markers including tumor markers
2. PET-CT scan (during fasting period: FDG injection, uptake, scan)
3. Abdominal and thyroid ultrasound
4. Chest X-ray and pulmonary function test
5. ECG and cardiac evaluation
Early Afternoon (12:00 PM – 2:00 PM):
6. Light meal provided by hospital
7. Gastroscopy under sedation (upper endoscopy)
8. Colonoscopy under sedation (performed back-to-back with gastroscopy while still sedated)
Late Afternoon (2:00 PM – 4:00 PM):
9. Recovery from sedation
10. Additional tests: brain MRI/MRA, cardiac CT (if in VIP package)
11. Specialist consultation: preliminary results review
Next Morning:
12. Full results consultation with physician: review of all findings, recommendations, follow-up plan
All of this (blood work, PET-CT, endoscopy, ultrasound, MRI, cardiac screening, and physician consultations) for $4,000-$6,500 at a top Korean university hospital. In the US, the PET-CT alone would cost more than the entire Korean package.
Ready to Book a PET-CT Screening in Korea?
We help international patients book full health checkups, with or without PET-CT, at Korea’s top university hospitals. We handle scheduling, hospital coordination, translation, and results delivery.
Tell us your age, health concerns, family cancer history, and screening goals, and we’ll recommend the right checkup package and hospital for you.